These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28720173)

  • 21. Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
    Ramachandran G; Chandrasekaran V; Hemanth Kumar AK; Dewan P; Swaminathan S; Thomas A
    Trop Med Int Health; 2013 Sep; 18(9):1141-1144. PubMed ID: 23937703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of antitubercular drugs by micellar electrokinetic capillary chromatography (MEKC).
    Acedo-Valenzuela MI; Espinosa-Mansilla A; Muñoz De La Peña A; Cañada-Cañada F
    Anal Bioanal Chem; 2002 Oct; 374(3):432-6. PubMed ID: 12373391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mathematical approach for the simultaneous in vitro spectrophotometric analysis of rifampicin and isoniazid from modified-release anti-TB drug delivery systems.
    du Toit L; Pillay V; Choonara Y
    Curr Drug Deliv; 2010 Jan; 7(1):5-12. PubMed ID: 19863485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazone.
    Mariappan TT; Jindal KC; Singh S
    J Pharm Biomed Anal; 2004 Nov; 36(4):905-8. PubMed ID: 15533688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
    Battini S; Mannava MKC; Nangia A
    J Pharm Sci; 2018 Jun; 107(6):1667-1679. PubMed ID: 29462633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
    Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
    Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets.
    Pouplin T; Phuong PN; Toi PV; Nguyen Pouplin J; Farrar J
    PLoS One; 2014; 9(7):e102047. PubMed ID: 25004128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of ethambutol hydrochloride in the combination tablets by precolumn derivatization.
    Yan M; Guo T; Song H; Zhao Q; Sui Y
    J Chromatogr Sci; 2007; 45(5):269-72. PubMed ID: 17555635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tackling quantitative polymorphic analysis through fixed-dose combination tablets production. Pyrazinamide polymorphic assessment.
    Antonio M; Raffaghelli M; Maggio RM
    J Pharm Biomed Anal; 2021 Feb; 194():113786. PubMed ID: 33281002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma.
    Smith PJ; van Dyk J; Fredericks A
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S325-8; discussion S351-2. PubMed ID: 10593712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high-throughput LC-MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma.
    Pršo K; Žideková N; Porvazník I; Solovič I; Mokrý J; Kertys M
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9425. PubMed ID: 36329637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification and determination of antitubercular compounds].
    Iwainsky H; Grunert M; Reutgen H; Sehrt I
    Pharmazie; 1970 Sep; 25(9):505-13. PubMed ID: 4922351
    [No Abstract]   [Full Text] [Related]  

  • 35. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
    Zhou Z; Wu X; Wei Q; Liu Y; Liu P; Ma A; Zou F
    Anal Bioanal Chem; 2013 Jul; 405(19):6323-35. PubMed ID: 23719934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHIH-DFT determination of the molecular structure infrared spectra, UV spectra and chemical reactivity of three antitubercular compounds: Rifampicin, Isoniazid and Pyrazinamide.
    Favila A; Gallo M; Glossman-Mitnik D
    J Mol Model; 2007 Apr; 13(4):505-18. PubMed ID: 17260147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic monitoring of antituberculosis drugs by direct in-line extraction on a high-performance liquid chromatography system.
    Seifart HI; Kruger PB; Parkin DP; van Jaarsveld PP; Donald PR
    J Chromatogr; 1993 Sep; 619(2):285-90. PubMed ID: 8263100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
    de Oliveira Neves AC; Soares GM; de Morais SC; da Costa FS; Porto DL; de Lima KM
    J Pharm Biomed Anal; 2012 Jan; 57():115-9. PubMed ID: 21908131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of chemometrics to compare NIR and HPLC for the simultaneous determination of drug levels in fixed-dose combination tablets employed in tuberculosis treatment.
    Teixeira KSS; da Cruz Fonseca SG; de Moura LCB; de Moura MLR; Borges MHP; Barbosa EG; De Lima E Moura TFA
    J Pharm Biomed Anal; 2018 Feb; 149():557-563. PubMed ID: 29197297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous Quantitation of Amlodipine Besylate and Olmesartan Medoxomil in Fixed-Dose Combination Tablets: HPLC-DAD Versus UHPLC-DAD.
    Almeida MO; Fernandes C; Pianetti GA; César IC
    J Chromatogr Sci; 2018 Apr; 56(4):344-350. PubMed ID: 29409036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.